Introduction
Medial-compartment knee osteoarthritis (OA) is a widespread and often disabling condition affecting the inner part of the knee joint. This type of OA commonly causes persistent pain on the inside of the knee, making it difficult to stand comfortably or walk for long periods. Thankfully, advances in treatment have introduced injectable therapies that aim to ease symptoms and improve joint function.
One such treatment gaining attention is Arthrosamid – an injectable gel designed specifically to cushion and support the knee joint. It targets the medial compartment, where cartilage damage and joint stress are most common. In this article, we’ll explore how Arthrosamid may help those living with medial-compartment knee OA, focusing on its potential to improve comfort when standing and increase walking endurance.
Understanding Medial-Compartment Knee Osteoarthritis
Medial-compartment knee OA involves the breakdown of cartilage mainly on the inner side of the knee. Unlike other types of knee OA that affect different parts of the joint, medial OA specifically impacts the inner compartment, often leading to pain and stiffness localized there.
This condition usually develops because of uneven loading on the joint – for example, varus alignment, where the knees bow outward, putting extra pressure on the inner knee. Over time, this increased load wears down cartilage, causing pain, reduced mobility, and difficulty with activities such as walking or standing for long periods.
The Mechanism and Promise of Arthrosamid
Arthrosamid is a novel injectable treatment made from polyacrylamide hydrogel, a biocompatible substance that mimics the cushioning effect of natural cartilage. When injected into the knee, it helps restore the joint’s shock absorption, reducing painful bone-on-bone contact.
Research shows that Arthrosamid is both safe and effective. As one study explains, “Arthrosamid® has been known to be safe and efficacious in knee osteoarthritis patients” (Gao et al., 2025). The treatment can significantly ease symptoms, improve daily comfort, and potentially delay the need for knee replacement surgery. Importantly, certain patients—particularly older individuals without diabetes and those with less severe OA—may benefit most. Another study highlights that patient factors such as “being older, having a lower knee OA grade, and not having diabetes” increase the chances of meaningful improvement after Arthrosamid injections (Gao et al., 2025).
Free non-medical discussion
Not sure what to do next?
Information only · No medical advice or diagnosis.
Patient Experience: Care and Professional Support
Professor Paul Lee is a leading expert in cartilage health and one of the foremost clinicians offering Arthrosamid treatment. He serves as an advisor to the Royal College of Surgeons of Edinburgh and is well regarded for his expertise in this field.
At the London Cartilage Clinic, Professor Lee and his team provide personalised care with a strong focus on clinical assessment and rehabilitation. Every patient receives tailored advice to suit their condition and lifestyle, ensuring the safest and most effective use of Arthrosamid as part of a comprehensive treatment plan.
Living with Medial-Compartment Knee OA: Practical Insights
Managing medial-compartment knee OA is about more than just injections. Patients often find relief through modified activities that reduce knee strain, targeted physiotherapy to strengthen supporting muscles, and lifestyle adjustments that support joint health.
Arthrosamid can fit into this overall management strategy as a supportive option that cushions the joint and helps maintain mobility. With guidance from healthcare professionals specialising in knee OA, patients can combine treatments like Arthrosamid with rehabilitation and lifestyle changes to maintain their quality of life.
Conclusion
Arthrosamid is a promising injectable therapy for medial-compartment knee osteoarthritis. By providing cushioning support, it can offer relief from inner-knee pain and help improve comfort during standing and walking. Its safety profile and clinical benefits make it a valuable option—especially for carefully selected patients under expert care.
If you experience inner-knee pain from medial OA, consulting healthcare professionals such as Professor Paul Lee and the London Cartilage Clinic team can provide personalised guidance and optimise your treatment outcomes.
For individual medical advice, please consult a qualified healthcare professional.
References
- Gao, H. C. K., Akhtar, M., Creedon, C., Nar, Ö., Verma, T., & Lee, P. Y. F. (2025). Polyacrylamide hydrogel injections in knee osteoarthritis: A PROMs-based 24 month cohort study. Journal of Clinical Orthopaedics and Trauma, 103136. https://doi.org/10.1016/j.jcot.2025.103136
- Gao, H. C. K., Akhtar, M., Creedon, C., Nar, Ö., & Lee, P. Y. (2025). The impact of patient factors on the minimal clinically important difference of Arthrosamid polyacrylamide hydrogel injection for knee osteoarthritis: A cohort study. Journal of Osteoarthritis and Cartilage. https://doi.org/10.1016/j.joca.2025.02.648
Frequently Asked Questions
- Arthrosamid is a unique injectable hydrogel designed to cushion and support the inner knee joint. It helps mimic natural cartilage, reducing painful bone-on-bone contact and potentially delaying the need for more invasive procedures.
- The London Cartilage Clinic, led by Professor Paul Lee, offers expert assessment, personalised care, and advanced injectable therapies like Arthrosamid. Their comprehensive approach ensures patients receive the best-suited management for their knee osteoarthritis.
- Professor Paul Lee is a cartilage expert, Royal College of Surgeons of Edinburgh Ambassador and Advisor. His extensive clinical experience ensures patients receive precise assessment and treatment planning, maximising the effectiveness and safety of therapies like Arthrosamid.
- During a consultation, patients undergo careful assessment, receive tailored advice, and benefit from detailed rehabilitation planning. The clinic’s team focuses on achieving the safest, most effective outcomes for each individual with medial-compartment knee osteoarthritis.
- While Arthrosamid offers many benefits, its suitability depends on individual factors such as the patient’s health and OA severity. Personalised consultations at the London Cartilage Clinic help determine the best and safest treatment options for each patient.
Legal & Medical Disclaimer
This article is written by an independent contributor and reflects their own views and experience, not necessarily those of London Cartilage Clinic. It is provided for general information and education only and does not constitute medical advice, diagnosis, or treatment.
Always seek personalised advice from a qualified healthcare professional before making decisions about your health. London Cartilage Clinic accepts no responsibility for errors, omissions, third-party content, or any loss, damage, or injury arising from reliance on this material.
If you believe this article contains inaccurate or infringing content, please contact us at [email protected].
London Cartilage Clinic
Ready to explore your options?
Our consultant-led team specialises in cartilage repair, regeneration and replacement — tailored to your diagnosis and long-term goals.
Will the Arthrosamid work for me
PAAG-8+ Questionnaire
A bright, structured entry point for patients exploring Arthrosamid. The questionnaire helps frame suitability, expectations, and 24-month clinical benefit discussion before a fuller consultant-led review.
Designed for shared decision-making. It does not replace specialist consultation, examination, imaging review, or formal medical advice.
